Indianapolis, IN · Founded 2020 · Privately Held (backing)
Operator of a pre-clinical stage biotechnology company intended to support a cancer treatment. Grannus Therapeutics is based in Indianapolis, IN and was founded in 2020. It was valued at $5 million at its seed round in Jan 2022, the last priced event on record. It has raised $2.9 million across 2 recorded rounds; the latest was an $800,000 debt round in Nov 2023.
PMV mark · valuation
$5.0M
Oct 2026
Priced at
its seed round
Jan 2022
Total raised
$2.9M
Last round
Debt
Nov 2023
Team — not yet on record
No current team members for Grannus Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Grannus Therapeutics with a free account
·Watch Grannus Therapeutics: the Monday email on marks, rounds and moves
